In the United States, every
two seconds someone requires blood either for routine medical procedures
or emergency situations. For patients suffering from acute and chronic medical
conditions, blood transfusion is an indispensable component of healthcare
capable of improving their life expectancy and overall quality of life. Approx. 29000
units of red blood cells, 5000 units of platelets,
and 6500 units of plasma are required every day in the United
States. According to the American Cancer Society, more
than 1.8 million people were diagnosed with cancer in 2020 and
required blood during their chemotherapy treatment.
The demand for blood is ever-increasing due to the rising number of accidents and injuries requiring blood transfusion, increasing incidences of severe anemia, expanding diagnostic and treatment options, and the emergence of new medical treatment regimens and procedures. In recent times, blood bag systems have become an indispensable and essential item for hospitals to meet the blood requirements for patients.
Used for collecting plasma and platelets, blood bags act as indispensable components of blood transfusion that maintain sterility of the blood and enhance the reliable collection, separation, storage, and transport of blood. More than 90% of all blood donations are processed through blood bag systems since they allow better separation of blood components in a sterile manner and allow safer transfusion. Blood bags are designed to withstand large temperature variations (–70°C to +120°C) and centrifugation.
Based upon the need for
infusion, blood bags can be differentiated into:
Single blood bag
- Designed for whole blood collection
- Contains 63 ml CPDA-1/CPD anticoagulant
solution
- Capacity ranges are 250 ml, 350 ml, 450 ml
- It contains a 16G tamper-proof needle and
standard donor tubing
Double blood bag
- Designed for separating whole blood into
plasma and red cells
- Eliminates the possibility of contamination
- The primary bag contains 63 ml CPDA-1/CPD
anticoagulant solution
- 300 ml transfusion bag contains no solution
Triple blood bag for separating packed cells, plasma, and
platelets
Quadruple blood bag for separating packed cells, plasma,
platelets, and cryoprecipitate
Generally, a blood bag
system consists of a collection tube, needle, needle cover, and clamp. Blood
bag systems have largely replaced the use of glass bottles since they require
thorough cleaning, rinsing, and autoclaving procedures and are vulnerable to
breakage during transportation. Besides, air bubbles in glass bottles could
lead to severe complications during a blood transfusion. On the contrary, blood
bags are made from plastic, polyvinyl chloride (PVC), or other materials
compatible with blood to reduce the risk of contamination. Unlike glass
bottles, blood bags contain anticoagulant and red blood cell preservative
solutions to maintain effectiveness.
Medical and surgical
manufacturers are increasingly focusing on developing items for single-use
applications. The main reason for this development is infection control.
‘One-time use’ items like disposable blood bags eliminate the risk of
transmission of infectious agents to subsequent patients. Besides, the demand
for blood bags is growing due to the hygienic methods adopted for their
manufacturing.
Manufacturing of Blood Bag
Systems
Polymers are of little
value unless compounded with additives such as plasticizers, stabilizers,
lubricants, etc., to make useful materials like plastic. Polyvinyl chloride
(PVC) is a commonly used material for manufacturing blood bags. Since PVCs are
hard and rigid, they are plasticized to provide flexibility to the bags and
tubes.
The plasticized material is
extruded through a die to convert it into a sheet form. The extruded sheet is
then cut into desired size and shape and welded to form donor and transfer tubing. The tubes are then
further printed and cut into appropriate lengths.
Injection
molding is a manufacturing process to produce components like transfusion port,
needle cover, clamp, etc., by injecting molten materials into a mold. The manufactured components are then sterilized
with ultraviolet light, dried in a drying oven, and cooled. Further, the needle
is fixed into the needle holder.
High-frequency welding is
used to fabricate blood bags by placing PVC sheets between electrodes and
applying high voltage simultaneously. Further, transfusion ports, donor, and
transfer tubing are organized in inappropriate positions regarding the bag. The
welded
bags are then trimmed, clamps
and needle coverings are fixed on the tubing, and sent to the labelling
section.
- Preparation of Anticoagulant Solution
Blood bags are filled with
anticoagulants to reduce or extend the blood clotting time period. Acid citrate
dextrose is a popular anticoagulant employed in blood bags to inhibit the
binding of calcium ions binding in the blood. The constituents of
anticoagulants are pre-mixed, and the solution is filled in the blood bags in
pyrogen-free distilled water.
Blood bags are sterilized
with autoclaves, in which sterilizing medium is a mixture of steam and air. One
of the counterpressure types of sterilization, known as ‘air-over-steam,’
allows control of sterilization pressure independently of the
temperature.
- Final Visual Inspection Stage
This step involves
eliminating particulate matter, leaks, and other visible defects. All the
relevant details regarding the blood bag are thoroughly investigated. The blood
bag should not contain any water vapor content to avoid anticoagulant
adulteration, the needle should not be bend, and there must be a needle
protector with the bag. The bags are subsequently packed and sent into the
packing section to ensure quality.
Blood and blood components
are always vulnerable to infectious agents as biological fluids. The Center
for Biologics Evaluation and Research (CBER) develops and ensures
quality standards related to products such as blood cell separation devices and
blood collection containers to maintain blood supply safety. The US Food and
Drug Administration has also strengthened its oversight of the blood industry
to reduce the risk of contamination to the lowest level without decreasing
availability of life-saving resources.
Now the blood
establishments must transport and distribute blood and blood components at all
stages of transfusion to maintain the quality of the product. As per the FDA
regulation, a blood bag not containing anticoagulant solution is treated as a
device, whereas a blood bag with the solution is treated as a drug-device
combination product but still regulated as a drug.
How Blood Bag System
Collects Blood?
The whole blood collection
set consists of the main donor bag with blood and small plastic bags attached,
which may be empty or full of nutrient fluid. The healthcare provider places
the product code label on the blood bag to indicate the components in which the
plasma should be segmented. Then the technician places the whole blood in a
centrifuge cup and then into the floor model centrifuge, which is the size of
the washing machine.
Then the blood spins and
separates, where RBCs reach the bottom of the donation bag, whereas plasma
floats on top. After the centrifuge stops spinning, the whole blood is removed
and placed in a machine that pushes the plasma out in one of the attached bags.
Then, the nutrient fluid stored in one of the attached bags is combined with
RBCs to last longer in the refrigerator. Then, white blood cells are filtered
out from the red blood cells floating in the nutrient-dense fluid. While RBCs
are placed in the fridge for future patient transfusion, the plasma product is
frozen and placed in a big freezer.
Role of RFID Technologies
to Reduce Blood Transfusion Errors
Blood
transfusion errors have remained a common occurrence at medical facilities due
to mishandling or other kind of manual interventions. However, Radio Frequency Identification
(RFID) technologies can help address human and systems errors in the blood transfusion
supply chain and ensure safe blood delivery.
RFID
integrated blood bags reduce the chances of errors and make transfusion processes
more robust. Besides, modern
technology plays an important role in generating logistic and temperature data
of blood products, which would be essential for optimizing the quality of the
blood transfusion chain. RFID is considered a more advanced and effective
technique than barcode to generate accurate data.
Way Ahead
Leading manufacturers
like Terumo BCT, Fresenius Kabi, Macopharma,
and others are introducing a comprehensive range of customized blood bags in
hospitals and transfusion centers to fulfill the demand for customized blood
bags in platelets and plasma collection procedures. Besides, there has been
increasing use of biodegradable thermoplastic polyurethane for making blood
bags to reduce plastic pollution caused by PVC plastic bags. With continuous
developments in blood collection technology and rising incidences of
blood-related disorders, the blood bag market is anticipated to grow further in
the coming years.
According to TechSci
Research report “United States Blood Bags Market By Product Type
(Single Blood Bag, Double Blood Bag, Triple Blood Bag, Quadruple Blood Bag,
Penta Blood Bag) By Type (Collection Bag v/s Transfer Bag) By Volume (100ml,
150ml, 250ml, 300ml, 350ml, 400ml, 450ml, 500ml) By Material (PVC, PET, Others)
By End User (Hospitals, Clinics, Ambulatory Surgical Center, Blood Banks,
Others) By Company, By Region, Forecast & Opportunities, 2026”, the United States
blood bags market is expected to grow at a significant rate owing to the rise
in government initiatives to promote blood donations. Besides, rising
incidences of chronic disorders and high occurrence of trauma and injuries are
contributing to the growth of the United States blood bags market.